NCT00262106 - Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection | Biotech Hunter

Enrollment

9,404

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

September 30, 2009

Conditions

HIV InfectionsGonorrheaChlamydial InfectionsGenital Herpes

Interventions

DRUG

PRO 2000/5

Gel

DRUG

Placebo

Trial Locations (6)

Reproductive Health and HIV Research Unit, Chris Hani Baragwanath Hospital, Bertsham

HIV Prevention Research Unit, Medical Research Council, Westville

Africa Centre for Health and Population Studies, Mtubatuba

AMREF Lake Zone Programme, Mwanza

MRC Programme on AIDS in Uganda, Uganda Virus Research Institute, Entebbe

MDP Zambia, Nakambala Sugar Estate, Mazabuka